Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Activation of the Nitric Oxide Pathway and Acute Myocardial Infarction Complicated by Acute Kidney Injury

J. Parenica, P. Kala, A. Mebazaa, S. Littnerova, K. Benesova, J. Tomandl, M. Goldbergová Pavkova, J. Jarkovský, J. Spinar, M. Tomandlova, M. Dastych, C. Ince, K. Helanova, M. Tesak, M. Helan, P. Lokaj, M. Legrand, GREAT Network

. 2020 ; 10 (2) : 85-96. [pub] 20200120

Jazyk angličtina Země Švýcarsko

Typ dokumentu srovnávací studie, časopisecké články, pozorovací studie, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21020805

BACKGROUND/AIMS: The pathophysiology of acute kidney injury (AKI) in ST-elevation myocardial infarction (STEMI) patients remains poorly explored. The involvement of the nitric oxide (NO) pathway has been demonstrated in experimental ischemic AKI. The aim of this study was to assess the predictive value of circulating biomarkers of the NO pathway for AKI in STEMI patients. METHODS: Four hundred and twenty-seven STEMI patients treated with primary percutaneous coronary intervention were included. The primary end point was AKI. Biomarkers of the NO pathway (plasma superoxide dismutase [SOD], uric acid, nitrite/nitrate [NOx], neopterin) as well as cardiac biomarkers (B-type natriuretic peptide [BNP] and troponin) were sampled 12 h after admission. The predictive value of circulating biomarkers was evaluated in addition to the multivariate clinical model. RESULTS: AKI developed in 8.9% of patients. The 3-month mortality was significantly higher in patients with AKI (34.2 vs. 4.1%; p < 0.001). SOD, uric acid, NOx, neopterin, BNP and troponin were significantly associated with the development of AKI (area under curve [AUC]-receiver operating curve [ROC] ranging between 0.70 and 0.81). In multivariate analysis cardiogenic shock, neopterin, NOx and troponin were independent predictors of AKI. AUC-ROC of the association of multibiomarkers and clinical model was 0.90 and outperformed the predictive value of the clinical model alone. OR of NOx ≥45 µmol/L was 8.0 (95% CI 3.1-20.6) for AKI. CONCLUSION: Biomarkers of the NO pathway are associated with the development of AKI in STEMI patients. These results provide insights into the pathophysiology of AKI and may serve at developing preventing strategies for AKI targeting this pathway.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21020805
003      
CZ-PrNML
005      
20210830102440.0
007      
ta
008      
210728s2020 sz f 000 0|eng||
009      
AR
024    7_
$a 10.1159/000503718 $2 doi
035    __
$a (PubMed)31958795
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Parenica, Jiri $u Department of Internal Medicine and Cardiology, University Hospital Brno, Brno, Czechia $u Faculty of Medicine, Masaryk University, Brno, Czechia
245    10
$a Activation of the Nitric Oxide Pathway and Acute Myocardial Infarction Complicated by Acute Kidney Injury / $c J. Parenica, P. Kala, A. Mebazaa, S. Littnerova, K. Benesova, J. Tomandl, M. Goldbergová Pavkova, J. Jarkovský, J. Spinar, M. Tomandlova, M. Dastych, C. Ince, K. Helanova, M. Tesak, M. Helan, P. Lokaj, M. Legrand, GREAT Network
520    9_
$a BACKGROUND/AIMS: The pathophysiology of acute kidney injury (AKI) in ST-elevation myocardial infarction (STEMI) patients remains poorly explored. The involvement of the nitric oxide (NO) pathway has been demonstrated in experimental ischemic AKI. The aim of this study was to assess the predictive value of circulating biomarkers of the NO pathway for AKI in STEMI patients. METHODS: Four hundred and twenty-seven STEMI patients treated with primary percutaneous coronary intervention were included. The primary end point was AKI. Biomarkers of the NO pathway (plasma superoxide dismutase [SOD], uric acid, nitrite/nitrate [NOx], neopterin) as well as cardiac biomarkers (B-type natriuretic peptide [BNP] and troponin) were sampled 12 h after admission. The predictive value of circulating biomarkers was evaluated in addition to the multivariate clinical model. RESULTS: AKI developed in 8.9% of patients. The 3-month mortality was significantly higher in patients with AKI (34.2 vs. 4.1%; p < 0.001). SOD, uric acid, NOx, neopterin, BNP and troponin were significantly associated with the development of AKI (area under curve [AUC]-receiver operating curve [ROC] ranging between 0.70 and 0.81). In multivariate analysis cardiogenic shock, neopterin, NOx and troponin were independent predictors of AKI. AUC-ROC of the association of multibiomarkers and clinical model was 0.90 and outperformed the predictive value of the clinical model alone. OR of NOx ≥45 µmol/L was 8.0 (95% CI 3.1-20.6) for AKI. CONCLUSION: Biomarkers of the NO pathway are associated with the development of AKI in STEMI patients. These results provide insights into the pathophysiology of AKI and may serve at developing preventing strategies for AKI targeting this pathway.
650    _2
$a akutní poškození ledvin $x etiologie $x metabolismus $x patofyziologie $7 D058186
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a biologické markery $x krev $7 D015415
650    _2
$a kardiorenální syndrom $x komplikace $7 D059347
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a multivariační analýza $7 D015999
650    _2
$a infarkt myokardu $x komplikace $x metabolismus $x mortalita $x patofyziologie $7 D009203
650    _2
$a natriuretický peptid typu B $x metabolismus $7 D020097
650    _2
$a oxid dusnatý $x metabolismus $7 D009569
650    _2
$a oxidační stres $x fyziologie $7 D018384
650    _2
$a koronární angioplastika $x škodlivé účinky $x metody $7 D062645
650    _2
$a prediktivní hodnota testů $7 D011237
650    _2
$a infarkt myokardu s elevacemi ST úseků $x patofyziologie $x chirurgie $7 D000072657
650    _2
$a kardiogenní šok $x komplikace $x metabolismus $7 D012770
650    _2
$a troponin $x metabolismus $7 D014336
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
655    _2
$a pozorovací studie $7 D064888
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kala, Petr $u Department of Internal Medicine and Cardiology, University Hospital Brno, Brno, Czechia $u Faculty of Medicine, Masaryk University, Brno, Czechia
700    1_
$a Mebazaa, Alexandre $u Université Paris Diderot, PRES Sorbonne Paris Cité, Paris, France $u Department of Anaesthesiology and Critical Care and Burn Unit, APHP, Saint Louis Lariboisière University Hospitals, Paris, France $u U 942 INSERM, Paris, France
700    1_
$a Littnerova, Simona $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czechia
700    1_
$a Benesova, Klara $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czechia
700    1_
$a Tomandl, Josef $u Department of Biochemistry, Faculty of Medicine, Masaryk University, Brno, Czechia
700    1_
$a Goldbergová Pavkova, Monika $u Institute of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czechia
700    1_
$a Jarkovský, Jiří $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czechia
700    1_
$a Spinar, Jindrich $u Department of Internal Medicine and Cardiology, University Hospital Brno, Brno, Czechia $u Faculty of Medicine, Masaryk University, Brno, Czechia
700    1_
$a Tomandlova, Marie $u Department of Biochemistry, Faculty of Medicine, Masaryk University, Brno, Czechia
700    1_
$a Dastych, Milan $u Department of Biochemistry, University Hospital Brno, Brno, Czechia $u Department of Laboratory Methods, Faculty of Medicine, Masaryk University, Brno, Czechia
700    1_
$a Ince, Can $u Department of Translational Physiology, Academic Medical Center, Amsterdam, The Netherlands
700    1_
$a Helanova, Katerina $u Department of Internal Medicine and Cardiology, University Hospital Brno, Brno, Czechia $u Faculty of Medicine, Masaryk University, Brno, Czechia
700    1_
$a Tesak, Martin $u Department of Internal Medicine and Cardiology, University Hospital Brno, Brno, Czechia $u Faculty of Medicine, Masaryk University, Brno, Czechia
700    1_
$a Helan, Martin $u Faculty of Medicine, Masaryk University, Brno, Czechia $u Department of Anaesthesiology and Intensive Care, St Anne's University Hospital, Brno, Czechia $u Intensive Care Research, International Clinical Research Centre (ICRC), Brno, Czechia
700    1_
$a Lokaj, Petr $u Department of Internal Medicine and Cardiology, University Hospital Brno, Brno, Czechia, alveus@seznam.cz $u Faculty of Medicine, Masaryk University, Brno, Czechia, alveus@seznam.cz
700    1_
$a Legrand, Matthieu $u Université Paris Diderot, PRES Sorbonne Paris Cité, Paris, France $u Department of Anaesthesiology and Critical Care and Burn Unit, APHP, Saint Louis Lariboisière University Hospitals, Paris, France $u U 942 INSERM, Paris, France $u F-CRIN-INI-CRCT Network, Nancy, France
710    2_
$a GREAT Network
773    0_
$w MED00207785 $t Cardiorenal medicine $x 1664-5502 $g Roč. 10, č. 2 (2020), s. 85-96
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31958795 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830102440 $b ABA008
999    __
$a ok $b bmc $g 1691396 $s 1141251
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 10 $c 2 $d 85-96 $e 20200120 $i 1664-5502 $m Cardiorenal medicine $n Cardiorenal Med $x MED00207785
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

Možnosti archivace